Buy Rating Affirmed for Cara Therapeutics: Promising Prospects for Oral Difelikefalin in Notalgia Paresthetica Treatment
TipRanksApr 12 18:16
Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.
Zhitong FinanceApr 10 18:40
Buy Rating Affirmed for Cara Therapeutics Amidst Promising Korsuva Ph 2/3 Program and Market Potential
TipRanksApr 10 18:35
Cara Therapeutics Analyst Ratings
BenzingaApr 10 18:33
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)
TipRanksMar 28 18:00
Cara Therapeutics Analyst Ratings
BenzingaMar 28 17:38
Cara Therapeutics Analyst Ratings
BenzingaMar 6 19:57
Canaccord Genuity Maintains Buy on Cara Therapeutics, Lowers Price Target to $10
BenzingaMar 6 19:58
Cara Therapeutics Analyst Ratings
BenzingaMar 5 19:29
Cara Therapeutics: Promising Phase 2/3 Trial Progression Fuels Buy Rating
TipRanksMar 5 18:55
Cara Therapeutics Analyst Ratings
BenzingaJan 23 06:06
Strategic Restructuring and Focus on NP Program Justify Buy Rating for Cara Therapeutics
TipRanksJan 23 04:22
HC Wainwright & Co. Maintains Buy on Cara Therapeutics, Lowers Price Target to $2.5
BenzingaDec 19, 2023 19:22
Needham Maintains Buy on Cara Therapeutics, Lowers Price Target to $6
BenzingaDec 18, 2023 23:29
Cara Therapeutics Analyst Ratings
BenzingaDec 18, 2023 23:28
Analysts Are Bullish on Top Healthcare Stocks: Viridian Therapeutics (VRDN), Cara Therapeutics (CARA)
TipRanksDec 18, 2023 23:10
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA)
TipRanksNov 15, 2023 01:50
Piper Sandler Downgrades Cara Therapeutics to Neutral, Lowers Price Target to $1
BenzingaNov 14, 2023 18:59
Cara Therapeutics Analyst Ratings
BenzingaNov 14, 2023 18:57
HC Wainwright & Co. Maintains Buy on Cara Therapeutics, Lowers Price Target to $7
BenzingaOct 19, 2023 18:49
No Data
No Data